Medicis to buy Graceway portfolio; Big Pharma companies compete for China's booming diabetes drug market;

 @FierceBiotech: With 20% of vote, Sanofi's Viehbacher is leading our poll on the most influential CEOs in pharma. Vote | Follow @FierceBiotech

 @JohnCFierce: If these Pharmasset drugs work as Gilead hopes, qualifies for '14 OK, then Gilead is a hero. If they don't, Gilead is a goat. Hero or goat. | Follow @JohnCFierce

 @RyanMFierce: Unfortunately for $REGN, it can undercut Lucentis price and still face uphill battle competing with off-label Avastin in wet AMD. | Follow @RyanMFierce

 @MaureenFierce: Celldex brain cancer vaccine increases survival in Phase II. Report | Follow @MaureenFierce

 @MarkHFierce: ImClone/Lilly's Erbitux and Roche's Tarceva as brain tumor treatment? Expanded indications would equal greater value. Story | Follow @MarkHFierce

> Medicis Pharmceutical has struck a deal to buy Graceway Pharmaceuticals' skin treatments and asthma medication out of bankruptcy for $455 million. Story

> Cleveland-based ChanRx has raised an undisclosed amount of money for its Series A. Release

Bloomberg reports on the intense rivalry among Big Pharma companies vying to grab a share of China's growing market for diabetes drugs. Story

> Horizon Discovery has inked a three-year tech access deal with the National Cancer Institute and the National Human Genome Research Institute. Story

Pharma News

 @FiercePharma: Regeneron prices wet AMD drug Eyela at $1850 per shot, $16K per yearr, compared with Roche's Lucentis at $24K annually. | Follow@FiercePharma

> Eyela may beat Lucentis on price, but what of Avastin? Story

> Ben Venue puts troubled plant on idle amid shortages. Article

> Amgen strikes Epogen deals with DaVita, Fresenius. News

> Co-pay cards prompt CVS to toss drugs off formulary. Report

Biotech IT News

> Tufts to tackle tough issue of lengthy trial startups. Story

> Perceptive Informatics survey focuses on role of imaging in clinical trials. Report

> Biotech billionaire mounts digital attack on cancer. Report

> Scripps begins world's largest computer-based project against malaria. News

> Biotech heavyweight Art Levinson takes chairman job at Apple.  Article

Medical Device News

> Covidien to buy BARRX for $325M. News

> FDA to investigate stent shrinkage. Article

> BeneChill names former Boston Sci exec as new CEO. Item

> Survey: Irish medtech companies looking to hire next year. Piece

And Finally... A group of investigators in the UK have been focused on using a new brand of cognitive therapy to treat depression. Release